tiprankstipranks
Trending News
More News >

MicroPort CardioFlow Schedules Board Meeting to Approve Annual Results

Story Highlights
MicroPort CardioFlow Schedules Board Meeting to Approve Annual Results

Don’t Miss TipRanks’ Half-Year Sale

MicroPort CardioFlow Medtech Corp. ( (HK:2160) ) has shared an update.

MicroPort CardioFlow Medtech Corp. has announced a board meeting scheduled for March 27, 2025, to consider and approve the annual results for the year ending December 31, 2024, and to discuss the potential recommendation of a final dividend. This meeting is significant as it will determine the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.

More about MicroPort CardioFlow Medtech Corp.

MicroPort CardioFlow Medtech Corp. is a company incorporated in the Cayman Islands, focusing on the medical technology industry with a specialization in cardiovascular products and services.

YTD Price Performance: 66.18%

Average Trading Volume: 2,948,860

Technical Sentiment Consensus Rating: Sell

Current Market Cap: HK$2.73B

For a thorough assessment of 2160 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1